Study of the association between the donors and recipients angiotensin-converting enzyme insertion/deletion gene polymorphism and the acute renal allograft rejection
- PMID: 26311652
- PMCID: PMC4544556
- DOI: 10.12860/jnp.2015.13
Study of the association between the donors and recipients angiotensin-converting enzyme insertion/deletion gene polymorphism and the acute renal allograft rejection
Abstract
Background: Angiotensin converting enzyme (ACE) is involved in various pathophysiological conditions including renal function. ACE levels are under genetic control.
Objectives: This study was designed to investigate the association between the donors and recipients ACE-I/D gene polymorphism and risk of acute rejection outcome in renal allograft recipients.
Patients and methods: ACE-I/D polymorphism was determined in 200 donor-recipient pairs who had been referred to Afzalipour hospital in Kerman. ACE-I/D polymorphism was detected using polymerase chain reaction (PCR). Acute rejection (AR) during at least six months post-transplantation was defined as a 20% increase in creatinine level from the postoperative baseline in the absence of other causes of graft dysfunction which responded to antirejection therapy.
Results: The observed allele frequencies were II 9.8%, ID 35.6% and DD 44.4% in donors and II 9.8%, ID 35.1% and DD 52.7% in recipients. There were no significant association between ACE genotypes and AR episodes (ORID=0.96 [0.18-5.00] and ORDD: 1.24 [0.25-6.07] for the donors) and (ORID: 0.29 [0.06-1.45] and ORDD: 0.75 [0.19-2.90] for the recipients).
Conclusions: It seems that donor and recipient ACE-I/D genotype might not be a risk factor for acute renal allograft rejection. However, due to conflicting results from this and other studies, multicenter collaborative studies with more participants and concomitant evaluation of ACE polymorphism with other polymorphisms in renin-angiotensin system (RAS) are suggested to determine whether ACE genotypes are significant predictors of renal allograft rejection.
Keywords: Acute rejection; Angiotensin-converting-enzyme; Gen polymorphism; Kidney transplant.
Similar articles
-
The effect of angiotensin converting enzyme gene polymorphism on chronic allograft dysfunction in living donor renal transplant recipients.Clin Transplant. 2002 Jun;16(3):173-9. doi: 10.1034/j.1399-0012.2002.01058.x. Clin Transplant. 2002. PMID: 12010139
-
The influence of angiotensin-converting enzyme gene of donor and recipient on the function of transplanted kidney.Transplant Proc. 2005 Mar;37(2):755-9. doi: 10.1016/j.transproceed.2004.12.175. Transplant Proc. 2005. PMID: 15848522
-
Correlation between angiotensin-converting enzyme gene insertion/deletion polymorphism and kidney graft long-term outcome in pediatric recipients: a single-center analysis.Transplantation. 1999 Feb 27;67(4):534-8. doi: 10.1097/00007890-199902270-00008. Transplantation. 1999. PMID: 10071023
-
Association between Angiotensin I-Converting Enzyme Insertion/Deletion Polymorphism and Prognosis of Kidney Transplantation: A Meta-Analysis.PLoS One. 2015 May 22;10(5):e0127320. doi: 10.1371/journal.pone.0127320. eCollection 2015. PLoS One. 2015. PMID: 26000752 Free PMC article.
-
Impact of recipient ACE I/D genotype on kidney function in renal transplant patients: a meta-analysis of cross-sectional and longitudinal studies.Pharmacogenomics. 2015 Nov;16(16):1887-902. doi: 10.2217/pgs.15.119. Epub 2015 Nov 11. Pharmacogenomics. 2015. PMID: 26555566
Cited by
-
The Role of Angiotensin-Converting Enzyme (ACE) Polymorphisms in the Risk of Development and Treatment of Diabetic Nephropathy.J Clin Med. 2024 Feb 8;13(4):995. doi: 10.3390/jcm13040995. J Clin Med. 2024. PMID: 38398308 Free PMC article.
-
Joint Assessment of Donor and Recipient hTERT Gene Polymorphism Provides Additional Information for Early Kidney Transplantation Outcomes.Med Sci Monit. 2017 Apr 14;23:1812-1818. doi: 10.12659/msm.900406. Med Sci Monit. 2017. PMID: 28410362 Free PMC article.
References
-
- Tonelli M, Wiebe N, Knoll G, Bello A, Browne S, Jadhav D. et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. 2011;11(10):2093–109. - PubMed
-
- Davis CL, Delmonico FL. Living-donor kidney transplantation: a review of the current practices for the live donor. J Am Soc Nephrol. 2005;16(7):2098–110. - PubMed
-
- Karthikeyan V, Karpinski J, Nair RC, Knoll G. The burden of chronic kidney disease in renal transplant recipients. Am J Transplant. 2004;4(2):262–9. - PubMed
-
- Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant. 2004;4(8):1289–95. - PubMed
-
- Pour-Reza-Gholi F, Daneshvar S, Nafar M, Firouzan A, Farrokhi F, Einollahi B. Potential risk factors for hypersensitization reflected by panel-reactive antibodies in dialysis patients. Transplant Proc. 2005;37(7):2936–8. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous